ArticleOncology letters2020

NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF-κB signaling pathways.

Fei Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.